Published April 23, 2020 | Version v1
Patent Open

METHODS AND COMPOSITIONS FOR TREATING CANCER WITH ECM-AFFINITY PEPTIDES LINKED TO IMMUNOTHERAPEUTIC ANTIBODIES

Description

The methods and compositions described herein address the need in the art by providing compositions and methods for a therapy with an antibody that is specifically targeted to and/or retained intra- or peri-tumorally, limiting systemic exposure and reducing side-effects. Accordingly, aspects of the disclosure relate to a composition comprising an immunotherapeutic antibody operatively linked to an extracellular matrix (ECM)-affinity peptide. An ECM-affinity peptide is one that has affinity for an extracellular matrix protein.

Files

US20200123228.pdf

Files (4.8 MB)

Name Size Download all
md5:d0c7df7ad53dcf056a5b3ae80f058028
4.8 MB Preview Download

Additional details

Identifiers

Patent application number
US 201816606539 A
Patent number
US 2020/0123228 A1
Other
oai:uchicago.tind.io:8106

Dates

Patent filed
2018-04-20

UChicago Information

Division(s)
Pritzker School of Molecular Engineering